Cardiology Practice Questions

Q: A 50-year-old male with a history of hypertension presents with sudden, severe chest pain radiating to the back. CT angiography reveals an aortic dissection. What is the best immediate management?

Blood pressure control with IV beta-blockers. ***Blood pressure control with IV beta-blockers*** - Immediate management of **aortic dissection** involves rapidly reducing **blood pressure** and **heart rate** to decrease shear stress on the aortic wall [2]. - **Intravenous beta-blockers** are the first-line agents for this purpose, as they achieve both **heart rate** and **blood pressure reduction** [3]. *Surgical repair* - While ultimately necessary for **Type A dissections** (involving the ascending aorta), it is not the *immediate* first step [2]. - **Hemodynamic stabilization** with medication is critical prior to surgery to reduce the risk of further dissection or rupture during transport and preparation. *Observation* - **Aortic dissection** is a medical emergency with high mortality if untreated [2]. - **Observation** alone is inappropriate and would lead to rapid deterioration and potentially death. *Administration of thrombolytics* - **Thrombolytics** are used to dissolve clots in conditions like **myocardial infarction** or **stroke** [1]. - In aortic dissection, thrombolytics are **contraindicated** as they can worsen bleeding and lead to catastrophic rupture.

Q: In a patient experiencing heart failure, enlargement of which vein may be visible as a sign of increased central venous pressure?

External jugular vein. ***External jugular vein*** - The **external jugular vein** is often visible externally when distended due to elevated **central venous pressure** in heart failure. - Its superficial location makes its engorgement a clinically observable sign of **jugular venous distension (JVD)**, indicating increased pressure in the right atrium [1]. *Cephalic vein* - The **cephalic vein** is located in the arm and is not directly reflective of **central venous pressure** or right heart function. - While it can be distended in conditions causing peripheral venous congestion, it is not a primary indicator of **heart failure** severity. *Basilic vein* - The **basilic vein** is also located in the arm and, like the cephalic vein, does not provide a direct assessment of **central venous pressure**. - Its distension would reflect more localized or peripheral venous issues rather than systemic heart failure. *Internal jugular vein* - The **internal jugular vein** is directly connected to the right atrium and is the most accurate reflection of **central venous pressure**; however, its pulsations are typically *not* directly visible as a distinct, engorged vein [1]. - Clinicians assess the **internal jugular vein** by observing the pulsations of the sternocleidomastoid muscle, which correspond to changes in its pressure, rather than direct visualization of the vein itself.

Q: A patient with a long-standing history of hypertension presents with a sudden onset of severe chest pain radiating to the back. Imaging reveals a dissection in the aorta. Which part is most commonly affected?

Ascending aorta. ### Ascending aorta - The **ascending aorta** is the most common site for **aortic dissection**, particularly in patients with **hypertension**, due to high shear stress and vulnerability at this location [1]. - Dissections in the ascending aorta (Type A dissections) are **medical emergencies** due to the risk of rupture, cardiac tamponade, and organ ischemia. *Aortic arch* - While dissections can involve the **aortic arch**, they are less common as the primary site of origin compared to the ascending aorta. - Dissections originating here are often extensions of ascending aortic dissections (Type A), or less commonly, arise primarily from the arch, presenting complex surgical challenges due to major vessel involvement. *Descending aorta* - Dissections originating in the descending aorta (Type B dissections), typically **distal to the left subclavian artery**, are less common than Type A dissections [1]. - While they can be severe, they are often managed medically unless complications like malperfusion or rapid expansion occur. *Abdominal aorta* - Dissections originating primarily in the **abdominal aorta** are relatively rare compared to those in the thoracic aorta. - Abdominal aortic pathology is more commonly associated with **aneurysms**, which are dilations, rather than dissections, although dissections can extend into this segment [1].

Q: In a clinical evaluation of a hypertensive patient, the most likely cause of an observed fourth heart sound (S4) is:

Ventricular hypertrophy. ***Ventricular hypertrophy*** - A **fourth heart sound (S4)** is typically caused by **atrial contraction** against a stiff, non-compliant ventricle [1], often seen in **ventricular hypertrophy** due to chronic hypertension. - The S4 signifies **diastolic dysfunction**, where the ventricle has difficulty relaxing and filling properly [1]. *Mitral valve prolapse* - **Mitral valve prolapse** is characterized by a **mid-systolic click** and a late-systolic murmur, not an S4. - It involves the **leaflet bulging** into the left atrium during systole, usually not leading to ventricular stiffness. *Aortic stenosis* - **Aortic stenosis** typically presents with a **systolic ejection murmur** that radiates to the carotids, often with a diminished S2. - While severe aortic stenosis can lead to left ventricular hypertrophy and thus an S4, the **primary cause** of S4 is the hypertrophy itself, not the stenosis directly. *Pericarditis* - **Pericarditis** often causes a **pericardial friction rub** and chest pain, and may lead to distant heart sounds in the case of effusions. - It does not directly cause an S4, which is related to ventricular stiffness during filling.

Q: A patient with suspected myocardial infarction has a troponin I level of 0.5 ng/mL (normal <0.4 ng/mL). What is the next best step in managing this patient?

Obtain 12-lead ECG. ***Obtain 12-lead ECG*** - An elevated **troponin I level** (even if mildly elevated above the normal threshold) in the context of suspected **myocardial infarction** necessitates further investigation to assess for acute cardiac injury [3]. - A **12-lead ECG** is crucial for identifying acute ischemic changes (e.g., **ST-segment elevation or depression**, **T-wave inversions**) which can guide immediate management decisions [1], [2]. *Discharge with lifestyle modification* - Discharging the patient with an elevated **troponin I** without further evaluation would be premature and potentially harmful, as it indicates ongoing myocardial injury. - **Lifestyle modifications** are important for long-term cardiovascular health but are not an immediate management step for acute cardiac symptoms and elevated biomarkers. *Repeat troponin in 3 hours* - While serial troponin measurements are essential for evaluating the **kinetics of cardiac injury**, an initial elevated value requires immediate assessment of the electrical activity of the heart. - Waiting to repeat troponin before getting an **ECG** could delay critical interventions if acute myocardial ischemia is present. *Immediate thrombolysis* - **Thrombolysis** is a treatment reserved for specific scenarios of **ST-elevation myocardial infarction (STEMI)** where percutaneous coronary intervention (PCI) is not immediately available. - Administering thrombolysis based solely on an elevated troponin without an **ECG** confirming STEMI or without consideration of contraindications would be inappropriate and potentially dangerous [2].

Q: In the management of myocardial infarction, which medication has been demonstrated to reduce mortality?

ACE inhibitors. ***ACE inhibitors*** - **ACE inhibitors** are crucial post-MI, particularly in patients with **ST-elevation myocardial infarction (STEMI)**, anterior infarcts, or those with signs of **heart failure (HF)**, as they improve long-term survival and reduce the risk of remodeling [2]. - They work by inhibiting **angiotensin-converting enzyme**, thereby reducing vasoconstriction, preventing sodium and water retention, and decreasing cardiac preload and afterload. *Calcium channel blockers (primarily for angina management)* - While effective for **symptomatic relief of angina** and **hypertension**, **calcium channel blockers** generally do not reduce mortality post-MI and can be harmful in patients with **left ventricular dysfunction** [1]. - They are primarily used to manage symptoms when **beta-blockers** are contraindicated or ineffective, rather than improving survival directly after an MI [1]. *Anticoagulants (prevent thrombus formation)* - **Anticoagulants** prevent the formation and growth of new thrombi and are vital in the acute phase of MI and for secondary prevention in high-risk patients. - However, their primary role is to **prevent thrombotic events** (like reinfarction or stroke), not directly reduce overall mortality in the same way neurohormonal blockers do. *Antiarrhythmic drugs (used for arrhythmias)* - **Antiarrhythmic drugs** are used to treat or prevent specific **malignant arrhythmias** that can occur post-MI, such as ventricular tachycardia or fibrillation, which are life-threatening. - While they can be life-saving in acute arrhythmic events, widespread prophylactic use of antiarrhythmics has not been shown to reduce overall mortality post-MI and some have been associated with increased mortality.

Q: A 65-year-old woman with atrial fibrillation and a CHA2DS2-VASc score of 4 is being managed with warfarin. What is the target INR range for stroke prevention in this patient?

2.0-3.0. ***2.0-3.0*** - For **atrial fibrillation** patients at moderate to high risk of stroke (CHA2DS2-VASc score ≥ 2), a target **INR range of 2.0-3.0** is recommended for stroke prevention with warfarin [1], [2]. - This range provides an optimal balance between reducing **thrombotic risk** and minimizing the risk of **major bleeding** events [1]. *1.5-2.0* - This **INR range** is generally considered **subtherapeutic** for stroke prevention in most patients with atrial fibrillation and would not provide adequate anticoagulation. - It may be appropriate for some specific indications, such as **venous thromboembolism (VTE) prophylaxis** in certain high-risk orthopedic surgeries, but not for atrial fibrillation. *2.5-3.5* - This **INR range** may be considered for patients with **mechanical heart valves** or in specific situations where a higher level of anticoagulation is required due to increased thromboembolic risk despite optimal INR control. - However, for most patients with non-valvular atrial fibrillation, an **INR of 2.0-3.0** is sufficient and safer. *3.0-4.0* - An **INR range** this high is generally associated with a significantly increased risk of **bleeding complications** without providing substantial additional benefit for stroke prevention in most atrial fibrillation patients. - Such high targets are rarely recommended and only in very specific, high-risk scenarios, often under close medical supervision.

Q: A 35-year-old woman presents with palpitations and anxiety. An ECG shows a regular, narrow-complex tachycardia at 160 bpm consistent with supraventricular tachycardia. What is the first-line treatment?

Adenosine. ***Adenosine*** - **Adenosine** is the **first-line pharmacological treatment** for hemodynamically stable patients with **supraventricular tachycardia (SVT)** due to its rapid onset and short half-life. - It works by transiently blocking the **AV node**, interrupting the re-entrant pathway responsible for most SVTs. *Calcium channel blocker* - While **calcium channel blockers** like verapamil or diltiazem can be used for rate control in SVT, they are generally **second-line treatments** after adenosine. - Their slower onset of action and longer duration of effect make them less ideal for immediate termination of acute SVT compared to adenosine. *Carotid sinus massage* - **Carotid sinus massage** is a **vagal maneuver** that can be attempted as a first-line intervention *before* pharmacological therapy in stable SVT. - However, the question asks for **first-line *treatment***, implying a pharmacological approach, and while valuable, vagal maneuvers are often insufficient to terminate SVT compared to adenosine. *Beta-blocker* - **Beta-blockers** can be used as **rate-controlling agents** in SVT and for long-term prevention, but they are not the immediate first-line agent for acute termination in hemodynamically stable patients. - Their onset of action is slower than adenosine, and other agents are often preferred for rapid conversion of SVT.

Q: A 70-year-old man presents with new-onset chest pain and ST elevation on ECG. What is the most likely underlying pathology?

Atherosclerotic plaque rupture. ***Atherosclerotic plaque rupture*** - The **ST elevation** on ECG and new-onset chest pain in an older patient suggest an acute myocardial infarction due to **plaque rupture** [3]. - This is a common cause of myocardial ischemia in the elderly, leading to **coronary artery occlusion** [1]. *Pulmonary embolism* - Typically presents with **dyspnea**, pleuritic chest pain, and may cause ST changes, but often leads to **more diffuse ST elevation** rather than localized elevation. - Lack of signs like **hemoptysis** or signs of right heart strain reduces its likelihood in this context. *Myocarditis* - While it can cause chest pain and ECG changes, it is more often associated with **viral infections** and does not commonly present as ST elevation in isolation. - Myocarditis also typically includes **elevated inflammatory markers** and might show **arrhythmias**, distinguishing it from acute myocardial infarction. *Pericarditis* - Usually characterized by **sharp chest pain** that improves with sitting forward and is often associated with a pericardial rub, not typically causing ST elevation. - ST elevation in pericarditis often shows a more **diffuse pattern** across multiple leads, differing from the localized elevation seen in myocardial infarction [2].

Question 1

A 50-year-old male with a history of hypertension presents with sudden, severe chest pain radiating to the back. CT angiography reveals an aortic dissection. What is the best immediate management?

Accepted Answer

Blood pressure control with IV beta-blockers

Answer

Surgical repair

Answer

Observation

Answer

Administration of thrombolytics

Question 2

In a patient experiencing heart failure, enlargement of which vein may be visible as a sign of increased central venous pressure?

Accepted Answer

External jugular vein

Answer

Cephalic vein

Answer

Basilic vein

Answer

Internal jugular vein

Question 3

A patient with a long-standing history of hypertension presents with a sudden onset of severe chest pain radiating to the back. Imaging reveals a dissection in the aorta. Which part is most commonly affected?

Accepted Answer

Ascending aorta

Answer

Aortic arch

Answer

Descending aorta

Answer

Abdominal aorta

Question 4

In a clinical evaluation of a hypertensive patient, the most likely cause of an observed fourth heart sound (S4) is:

Accepted Answer

Ventricular hypertrophy

Answer

Mitral valve prolapse

Answer

Aortic stenosis

Answer

Pericarditis

Question 5

A 60-year-old male with a history of myocardial infarction presents with new-onset heart failure symptoms. An echocardiogram shows severe mitral regurgitation. What is the most appropriate management option for this patient?

Accepted Answer

Mitral valve repair to improve symptoms and prevent further cardiac deterioration.

Answer

Medical management to stabilize symptoms.

Answer

Observation with repeat echocardiogram in 3 months.

Answer

Initiate anticoagulation to prevent thromboembolism.

Question 6

A patient with suspected myocardial infarction has a troponin I level of 0.5 ng/mL (normal <0.4 ng/mL). What is the next best step in managing this patient?

Accepted Answer

Obtain 12-lead ECG

Answer

Discharge with lifestyle modification

Answer

Repeat troponin in 3 hours

Answer

Immediate thrombolysis

Question 7

In the management of myocardial infarction, which medication has been demonstrated to reduce mortality?

Accepted Answer

ACE inhibitors

Answer

Calcium channel blockers (primarily for angina management)

Answer

Anticoagulants (prevent thrombus formation)

Answer

Antiarrhythmic drugs (used for arrhythmias)

Question 8

A 65-year-old woman with atrial fibrillation and a CHA2DS2-VASc score of 4 is being managed with warfarin. What is the target INR range for stroke prevention in this patient?

Accepted Answer

2.0-3.0

Answer

1.5-2.0

Answer

2.5-3.5

Answer

3.0-4.0

Question 9

A 35-year-old woman presents with palpitations and anxiety. An ECG shows a regular, narrow-complex tachycardia at 160 bpm consistent with supraventricular tachycardia. What is the first-line treatment?

Accepted Answer

Adenosine

Answer

Calcium channel blocker

Answer

Carotid sinus massage

Answer

Beta-blocker

Question 10

A 70-year-old man presents with new-onset chest pain and ST elevation on ECG. What is the most likely underlying pathology?

Accepted Answer

Atherosclerotic plaque rupture

Answer

Pericarditis

Answer

Myocarditis

Answer

Pulmonary embolism

Cardiology — MCQs

Cardiology — MCQs

On this page

Practice by Chapter

Want unlimited practice?